Login
Evidence Feed
About
Diagnostics
New
Top genes
FAQ
Contact us
^
Login
Contact us
to learn more about
our Premium Content: News alerts, weekly reports and conference planners
BIOMARKER:
JAK2 mutation
i
Other names:
JTK10, THCYT3, JAK2, Janus Kinase 2, Tyrosine-Protein Kinase JAK2, JAK-2
Contact us
to learn more about our Premium Content:
News alerts, weekly reports and conference planners
Entrez ID:
3717
Related biomarkers:
Expression
Mutation
CNA
Fusion
Others
‹
JAK2 underexpression (5)
JAK2 overexpression (1)
JAK2 underexpression (5)
JAK2 overexpression (1)
›
Associations
News
Trials
VERI cancer hierarchy
Reset Filters
JAK2 mutation
Acute Myelogenous Leukemia
JAK2 mutation
Acute Myelogenous Leukemia
ruxolitinib
Sensitive: C2 – Inclusion Criteria
ruxolitinib
Sensitive
:
C2
ruxolitinib
Sensitive: C2 – Inclusion Criteria
ruxolitinib
Sensitive
:
C2
JAK2 mutation
Leukemia
JAK2 mutation
Leukemia
ruxolitinib
Sensitive: C2 – Inclusion Criteria
ruxolitinib
Sensitive
:
C2
ruxolitinib
Sensitive: C2 – Inclusion Criteria
ruxolitinib
Sensitive
:
C2
JAK2 mutation
Acute Myelogenous Leukemia
JAK2 mutation
Acute Myelogenous Leukemia
LY3009120
Sensitive: C3 – Early Trials
LY3009120
Sensitive
:
C3
LY3009120
Sensitive: C3 – Early Trials
LY3009120
Sensitive
:
C3
JAK2 mutation
Acute Myelogenous Leukemia
JAK2 mutation
Acute Myelogenous Leukemia
DT2216
Sensitive: D – Preclinical
DT2216
Sensitive
:
D
DT2216
Sensitive: D – Preclinical
DT2216
Sensitive
:
D
^
^
Full access to predictive biomarker details and heatmap analytics are available with a VERI Account.
Sign up for FREE
Already have an account?
Login
Full access to predictive biomarker details and heatmap analytics are available with a VERI Account.
Sign up for FREE
Already have an account?
Login